Marketplace
Filters:
MedicineKeywords: |
NAHQ Releases Third Edition of Popular Healthcare Quality and Safety Resource: Q Solutions: Essential Resources for the Healthcare Quality ProfessionalThe National Association for Healthcare Quality (NAHQ) announces the release of the complete third edition of their respected foundational publication Q Solutions: Essential Resources for the Healthcare Quality Professional. The new text expands and reinforces the foundational knowledge for healthcare quality and patient safety professionals working across the care continuum. |
Released: 5/21/2013 4:05 PM EDT
National Association for Healthcare Quality |
BusinessKeywords: |
Columbia Licenses 3-D Organ & Tumor Imaging Software to VarianColumbia University has signed a licensing agreement with Varian Medical Systems for novel imaging software that facilitates 3-D segmentation, the process by which anatomical structures in medical images are distinguished from one another—an important step in the precise planning of cancer surgery and radiation treatments. |
Released: 5/16/2013 7:00 PM EDT
Columbia University Medical Center |
Medicine |
Centura Health Cancer Network Becomes First Integrated Network Cancer Program in ColoradoCentura Health Cancer Network was awarded silver accreditation by the American College of Surgeons Commission on Cancer, becoming the first Integrated Network Cancer Program in Colorado. |
Released: 5/10/2013 5:00 PM EDT
Porter Adventist Hospital |
BusinessChannels:Keywords: |
UAB Launches Company to ID Source and Nature of Cyber ThreatsIn a private-public partnership, the University of Alabama at Birmingham has launched Malcovery, an intelligence company specializing in cyber threat detection, to help businesses protect themselves from cyberattacks. Malcovery uses patented forensic technology to identify the source and nature of immediate cyberattacks and analyze millions of cyberthreat angles to combat future crises. |
Released: 5/10/2013 4:40 PM EDT
University of Alabama at Birmingham |
BusinessKeywords: |
TSRI and Janssen Ink New Research and License AgreementThe Scripps Research Institute (TSRI) today announced a five-year agreement with Janssen Pharmaceuticals, Inc. (Janssen) to collaborate on focused research projects in the infectious disease area, with the initial project targeting the influenza virus. Under the agreement Janssen will receive certain license rights to the results of the research. Janssen Pharmaceuticals will collaborate in the research on influenza through its Crucell Vaccine Institute. |
Released: 5/7/2013 7:00 AM EDT
Scripps Research Institute |
BusinessKeywords: |
Wolters Kluwer Health and BMJ Expand Publishing Agreement; BMJ Clinical Evidence Now Available on OvidWolters Kluwer Health announced today that it has expanded its partnership with BMJ to be the exclusive aggregated information provider of the BMJ Clinical Evidence resource on its OvidSP platform. Ovid will offer BMJ Clinical Evidence to medical and academic institutions globally to support clinicians, researchers, educators and students make decisions on quality care and improve patient outcomes through effective evidence-based clinical practice. |
Released: 5/2/2013 10:00 AM EDT
Wolters Kluwer Health |
MedicineChannels: |
Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical MedicationAbsorption Pharmaceuticals announced today that the U.S. Patent and Trademark Office has indicated that it will grant a patent related to the use of its topical medication, Promescent, for premature ejaculation (PE). The patent protects novel lidocaine-only eutectic formulation which enables maximum absorption of the anesthetic through the skin's outer layer and provides men with improved ejaculatory control while maintaining great sensory feeling. |
Released: 4/29/2013 9:05 AM EDT
Absorption Pharmaceuticals |
MedicineBusinessChannels:Keywords: |
Immudex Takes On International Proficiency PanelsImmudex has entered into a strategic agreement with the US Cancer Immunotherapy Consortium (CIC) of the Cancer Research Institute, and the European Association for Cancer Immunotherapy (CIMT), under which Immudex will provide MHC-peptide multimer and Elispot proficiency panel services worldwide. |
Released: 4/24/2013 9:00 AM EDT
Cancer Research Institute |
BusinessChannels:Keywords: |
PowerPot Turns Heat and Water into ElectricityUniversity of Utah students have invented a portable cook pot that doubles as a thermoelectric generator, and are now marketing it nationally after having raised $126K on Kickstarter. |
Released: 4/16/2013 11:00 AM EDT
University of Utah |
LifeEducation |
Saint Mary’s College Announces Four-Year Graduation PromiseAt a time when the national dialogue about higher education is centered on cost and value, Saint Mary’s College is proud to announce the Four-Year Graduation Promise. Starting in the fall with the incoming Class of 2017, students who follow the promise’s guidelines are guaranteed to graduate in four years or the College will pay for any additional courses a student needs to earn her degree. No other college or university in the area offers such a promise. |
Released: 4/3/2013 4:30 PM EDT
Saint Mary's College |
